Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine

RIO DE JANEIRO (Reuters) – Brazil health regulator Anvisa on Wednesday said it approved emergency use of the COVID-19 vaccine developed by Johnson & Johnson subsidiary Janssen.

(Reporting by Pedro Fonseca)